as on January 28, 2026 at 9:31 pm IST
Day's Low
Day's High
0.22%
Downside
6.48%
Upside
52 Week's Low
52 Week's High
68.25%
Downside
58.96%
Upside
Check Artiva Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$82.8M
EPS (TTM)
-3.09
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-86.18%
Compare market cap, revenue, PE, and other key metrics of Artiva Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $82.8M | NA | NA | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Artiva Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Artiva Biotherapeutics Inc investment value today
Current value as on today
₹89,248
Returns
Returns from Artiva Biotherapeutics Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Search interest for Artiva Biotherapeutics Inc Stock has decreased by -78% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 6 months, ARTV stock has moved up by 63.9%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 61.1%
| Organisation | Artiva Biotherapeutics Inc |
| Headquarters | 5505 Morehouse Drive, San Diego, CA, United States, 92121 |
| CEO | Dr. Fred Aslan M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Feng Xu | Senior Vice President of Biometrics |
Dr. Fred Aslan M.D. | President, CEO & Director |
Mr. John O'Neil CPA | Vice President of Finance |
Dr. Heather Raymon Ph.D. | Senior Vice President of Research & Early Development |
Mr. Benjamin Dewees | Senior Vice President of Regulatory Affairs |
Dr. Subhashis Banerjee M.D. | Chief Medical Officer |
Ms. Jennifer Kinsbruner Bush Esq., J.D. | Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer |
Dr. Peter Flynn Ph.D. | Co-Founder & Strategic Advisor |
Mr. Christopher P. Horan | Chief Technical Operations Officer |
Dr. David Moriarty Ph.D. | Senior VP of Clinical Operations |
Artiva Biotherapeutics Inc share price today is $4.63 as on . Artiva Biotherapeutics Inc share today touched a day high of $4.93 and a low of $4.62.
Artiva Biotherapeutics Inc share touched a 52 week high of $7.36 on and a 52 week low of $1.47 on . Artiva Biotherapeutics Inc stock price today i.e. is trending at $4.63,which is 37.09% down from its 52 week high and 214.97% up from its 52 week low.
Artiva Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Artiva Biotherapeutics Inc (ARTV) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Artiva Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Artiva Biotherapeutics Inc share’s latest price of $4.63 as on January 28, 2026 at 9:31 pm IST, you will get 2.1598 shares of Artiva Biotherapeutics Inc. Learn more about
fractional shares .